fenofibrate has been researched along with Hyperplasia in 4 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We assessed lipid profiles, plasma CET activity, and in-stent intimal hyperplasia after fenofibrate treatment in patients who underwent elective coronary stenting." | 9.14 | Effects of fenofibrate on lipid profiles, cholesterol ester transfer activity, and in-stent intimal hyperplasia in patients after elective coronary stenting. ( Daida, H; Hiki, M; Kiyanagi, T; Kume, A; Kurata, T; Miyauchi, K; Miyazaki, T; Mokuno, H; Okazaki, S; Sato, H; Shimada, K; Sumiyoshi, K; Tanimoto, K, 2010) |
| "Fenofibrate-treated group showed a significant reduction in neointimal formation (0." | 5.37 | Inhibitory effect of fenofibrate on neointima hyperplasia via G(0)/G(1) arrest of cell proliferation. ( Kim, DW; Kim, TJ; Kwon, JS; Lee, JJ; Lim, Y; Myung, CS; Yu, JY; Yun, YP; Zhang, WY, 2011) |
| "Fenofibrate was tested in vivo, in 30 coronary arteries of 10 pigs (1g/day, orally) and was compared to placebo." | 5.33 | Efficacy of peroxisome proliferative activated receptor (PPAR)-alpha ligands, fenofibrate, on intimal hyperplasia and constrictive remodeling after coronary angioplasty in porcine models. ( Aihara, K; Daida, H; Kasai, T; Miyauchi, K; Yokoyama, T, 2006) |
| "The PPAR-gamma ligand rosiglitazone, but not the PPAR-alpha ligand fenofibrate, decreases intimal hyperplasia following balloon injury in both fatty and lean Zucker rats." | 3.72 | Differential effects of peroxisome proliferator activator receptor-alpha and gamma ligands on intimal hyperplasia after balloon catheter-induced vascular injury in Zucker rats. ( Desouza, CV; Diez, J; Dunne, B; Fonseca, VA; Matta, AS; McNamara, DB; Murthy, SN, 2003) |
| "Fenofibrate was tested in vivo, in 30 coronary arteries of 10 pigs (1g/day, orally) and was compared to placebo." | 1.33 | Efficacy of peroxisome proliferative activated receptor (PPAR)-alpha ligands, fenofibrate, on intimal hyperplasia and constrictive remodeling after coronary angioplasty in porcine models. ( Aihara, K; Daida, H; Kasai, T; Miyauchi, K; Yokoyama, T, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyazaki, T | 1 |
| Shimada, K | 1 |
| Miyauchi, K | 2 |
| Kume, A | 1 |
| Tanimoto, K | 1 |
| Kiyanagi, T | 1 |
| Sumiyoshi, K | 1 |
| Hiki, M | 1 |
| Mokuno, H | 1 |
| Okazaki, S | 1 |
| Sato, H | 1 |
| Kurata, T | 1 |
| Daida, H | 2 |
| Lee, JJ | 1 |
| Yu, JY | 1 |
| Zhang, WY | 1 |
| Kim, TJ | 1 |
| Lim, Y | 1 |
| Kwon, JS | 1 |
| Kim, DW | 1 |
| Myung, CS | 1 |
| Yun, YP | 1 |
| Desouza, CV | 1 |
| Murthy, SN | 1 |
| Diez, J | 1 |
| Dunne, B | 1 |
| Matta, AS | 1 |
| Fonseca, VA | 1 |
| McNamara, DB | 1 |
| Kasai, T | 1 |
| Yokoyama, T | 1 |
| Aihara, K | 1 |
1 trial available for fenofibrate and Hyperplasia
| Article | Year |
|---|---|
Effects of fenofibrate on lipid profiles, cholesterol ester transfer activity, and in-stent intimal hyperplasia in patients after elective coronary stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Cholesterol Esters; Cholesterol, HDL; Cholesterol, LDL; Drug-E | 2010 |
3 other studies available for fenofibrate and Hyperplasia
| Article | Year |
|---|---|
Inhibitory effect of fenofibrate on neointima hyperplasia via G(0)/G(1) arrest of cell proliferation.
Topics: Angioplasty, Balloon; Animals; Becaplermin; Cell Proliferation; Cyclin D; Cyclin E; Cyclin-Dependent | 2011 |
Differential effects of peroxisome proliferator activator receptor-alpha and gamma ligands on intimal hyperplasia after balloon catheter-induced vascular injury in Zucker rats.
Topics: Animals; Biomarkers; Blood Glucose; Body Weight; Catheterization; Cholesterol; Diabetes Mellitus, Ty | 2003 |
Efficacy of peroxisome proliferative activated receptor (PPAR)-alpha ligands, fenofibrate, on intimal hyperplasia and constrictive remodeling after coronary angioplasty in porcine models.
Topics: Angioplasty, Balloon, Coronary; Animals; Coronary Restenosis; Coronary Vessels; Fenofibrate; Hyperpl | 2006 |